TNFSF14 Antikörper (Middle Region)
-
- Target Alle TNFSF14 Antikörper anzeigen
- TNFSF14 (Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14))
-
Bindungsspezifität
- Middle Region
-
Reaktivität
- Human, Hund
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TNFSF14 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Kreuzreaktivität
- Hund
- Aufreinigung
- Purified
- Immunogen
- TNFSF14 antibody was raised in rabbit using the middle region of TNFSF14 as the immunogen
- Top Product
- Discover our top product TNFSF14 Primärantikörper
-
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14) (AA 62-240) antibody
TNFSF14 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14) (AA 61-170) antibodyTNFSF14 Reaktivität: Human WB, ELISA, IP, IHC (p) Wirt: Maus Monoclonal 4E3 unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14) (AA 141-240) antibodyTNFSF14 Reaktivität: Maus, Ratte WB, FACS, IF (cc), IF (p), IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14) (AA 51-239) antibodyTNFSF14 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14) (AA 62-240) antibodyTNFSF14 Reaktivität: Human WB, IHC, IP, ICC Wirt: Maus Monoclonal C1 unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14) (AA 1-239) antibodyTNFSF14 Reaktivität: Human WB, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14) (Internal Region) antibodyVerified TNFSF14 Reaktivität: Human WB, ELISA, IF Wirt: Ziege Polyclonal unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14) (AA 58-239) antibodyTNFSF14 Reaktivität: Ratte WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14) (AA 1-204) antibodyTNFSF14 Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
-
- Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - Kommentare
-
TNFSF14 Blocking Peptide, catalog no. 33R-1573, is also available for use as a blocking control in assays to test for specificity of this TNFSF14 antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Konzentration
- Lot specific
- Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- Target
- TNFSF14 (Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14))
- Andere Bezeichnung
- TNFSF14 (TNFSF14 Produkte)
- Synonyme
- TNFSF14 antikoerper, CD258 antikoerper, HVEML antikoerper, LIGHT antikoerper, LTg antikoerper, TR2 antikoerper, HVEM-L antikoerper, Ly113 antikoerper, TNF superfamily member 14 antikoerper, tumor necrosis factor (ligand) superfamily, member 14 antikoerper, TNFSF14 antikoerper, Tnfsf14 antikoerper
- Hintergrund
- TNFSF14 is the cytokine that binds to TNFRSF3/LTBR. Binding to the decoy receptor TNFRSF6B TNFSF14 modulates its effects. TNFSF14 activates NFKB, stimulates the proliferation of T-cells, and inhibits growth of the adenocarcinoma HT-29. TNFSF14 acts as a receptor for Herpes simplex virus. Synonyms: Polyclonal TNFSF14 antibody, Anti-TNFSF14 antibody, tumor necrosis factor, ligand superfamily, member 14 antibody, CD258 antibody, HVEML antibody, LIGHT antibody, LTg antibody, TR2 antibody.
- Pathways
- Cancer Immune Checkpoints
-
